[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100464874":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":44,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":67,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Besancon","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Patients undergoing extracorporeal photochemotherapy",null,[12],"Other: Samples collection",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Samples collection","Sampling of 2 samples on the extracorporeal photochemotherapy circuit, before and after sensitization with 8-MOP and UVA irradiation (without additional puncture)",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Charline VAUCHY, PhD","CONTACT","+33381218875","cvauchy@chu-besancon.fr",[25],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Centre Hospitalier Universitaire de Besançon","RECRUITING","Besançon","25000","France","FR",{"type":33,"coordinates":34},"Point",[35,36],6.01815,47.24878,{"lat":36,"lon":35},[39,41],{"name":40,"role":21,"phone":10,"phoneExt":10,"email":23},"Charline Vauchy, PhD",{"name":42,"role":43,"phone":10,"phoneExt":10,"email":10},"Thomas CREPIN, MD","PRINCIPAL_INVESTIGATOR",{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100464874","morphee--mechanisms-of-cell-death-induced-by-extracorporeal-photochemotherapy-100464874",false,"NCT05333367","MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy","MORPHEE","Inclusion Criteria:\n\n* Adult patients\n* Treated with ECP for at least 1 month, for control of GVHD in hematopoietic cell allograft (acute or chronic GVHD), treatment and control of cellular or humoral rejection in solid organ transplantation (heart, lung, kidney) or in the treatment of cutaneous T-cell lymphoma\n\nExclusion Criteria:\n\n* Subjects with limited legal capacity.\n* Subjects judged by the investigator to be unlikely to comply with study procedures\n* Subjects with no social security coverage.\n* Pregnant women.\n* Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.","ALL","18 Years","85 Years",{"count":57,"type":58},20,"ESTIMATED","INTERVENTIONAL",[61],"NA","The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.",[64,65,66],"Cutaneous T-Cell Lymphoma","Graft Vs Host Disease","Graft Rejection",[68,69],"Cell death","Extracorporeal Photochemotherapy","2024-11-19",{"date":72,"type":73},"2024-11-21","ACTUAL",{"date":75,"type":73},"2022-04-15",{"date":77,"type":58},"2025-07",{"name":5,"class":6},1]